30 results on '"Hayden, Frederick G"'
Search Results
2. The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009—2010 Influenza A Virus Subtype H1N1 Pandemic
3. Combination Antiviral Therapy for Influenza: Predictions From Modeling of Human Infections
4. Emerging Influenza Antiviral Resistance Threats
5. End Points for Testing Influenza Antiviral Treatments for Patients at High Risk of Severe and Life-Threatening Disease
6. Seasonal Influenza in Adults and Children—Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
7. John F. Enders Lecture 2006: Antivirals for Influenza
8. Seasonal and Pandemic Influenza: Recommendations for Preparedness in the United States
9. Antiviral Management of Seasonal and Pandemic Influenza
10. Comparative Activities of Oseltamivir and A-322278 in Immunocompetent and Immunocompromised Murine Models of Influenza Virus Infection
11. Recovery of Drug-Resistant Influenza Virus from Immunocompromised Patients: A Case Series
12. Influenza Treatment with Neuraminidase Inhibitors: Cost-Effectiveness and Cost-Utility in Healthy Adults in the United Kingdom
13. Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment with or without Postexposure Prophylaxis
14. Accumulation of Defective Neuraminidase (NA) Genes by Influenza a Viruses in the Presence of NA Inhibitors as a Marker of Reduced Dependence on NA
15. Selection of Influenza Virus Mutants in Experimentally Infected Volunteers Treated with Oseltamivir
16. Effect of Rimantadine Treatment on Clinical Manifestations and Otologic Complications in Adults Experimentally Infected with Influenza A (H1N1) Virus
17. Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model
18. Effects of the Neuraminidase Inhibitor Zanamivir on Otologic Manifestations of Experimental Human Influenza
19. Antivirals for Pandemic Influenza
20. Respiratory Syncytial Virus Antivirals: Problems and Progress.
21. Intranasal Interferon α2 for Prevention of Rhinovirus Infection and Illness
22. Ineffectiveness of Recombinant $Interferon-β_{serine}$ Nasal Drops for Prophylaxis of Natural Colds [with Discussion]
23. Therapeutic Effects of Aerosolized Amantadine in Naturally Acquired Infection Due to Influenza A Virus
24. Prolonged Shedding of Amantadine-Resistant Influenza A Viruses by Immunodeficient Patients: Detection by Polymerase Chain Reaction-Restriction Analysis
25. Experimental Therapies for Ebola Virus Disease: What Have We Learned?
26. Overview of the 3rd isirv-Antiviral Group Conference - advances in clinical management.
27. Advances in antivirals for non-influenza respiratory virus infections.
28. Second isirv antiviral group conference: overview.
29. Newer influenza antivirals, biotherapeutics and combinations.
30. COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.